Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.1
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Share-Based Compensation Expense
Share-Based Compensation Expense
The Company records share-based compensation expense on a straight-line basis over the related vesting period and recognizes forfeitures as they occur. The following table sets forth share-based compensation expense included in selling, general and administrative expense in the condensed consolidated statements of operations:
Three Months Ended March 31,
(in thousands)
2022 2021
$899 $320
Schedule of Stock Option Activity
Stock option activity under all of the Company’s Plans during the three months ended March 31, 2022 is summarized below:
Stock Options Weighted-average
Exercise price
per share
Weighted-average
Remaining Contractual Life (in years)
Intrinsic
Value(1)
(in thousands)
Outstanding at December 31, 2021 1,350,473  $ 10.10 
Granted —  — 
Exercised (1,000) $ 2.60 
Forfeited or expired (24,933) $ 37.68 
Outstanding at March 31, 2022 1,324,540  $ 9.59  6.25 $ 7,499 
(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.
Schedule of Restricted Stock Awards Activity
Restricted Stock Activity
Restricted stock award ("RSA") activity for the three months ended March 31, 2022 is summarized below:
Restricted Stock Award Weighted - Average
Grant
Date Fair Value
Outstanding at December 31, 2021 380,105  $ 10.41 
Granted 39,916  $ 8.63 
Vested (10,089) $ 9.77 
Forfeited or expired (10,000) $ 20.45 
Outstanding at March 31, 2022 399,932  $ 9.79 
Schedule of Common Stock Warrant Activity
Common stock warrant activity for the three months ended March 31, 2022 is as follows:
Warrant
Shares
Weighted-average
Exercise price
per share
Intrinsic
Value(1)
(in thousands)
Outstanding at December 31, 2021 668,907  $ 2.97 
Exercised (14,728) $ 2.20 
Outstanding at March 31, 2022
654,179  $ 2.98  $ 5,071 
(1) Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the warrant exercise price of in-the-money warrants.